SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'GMP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BDM_A_TMIA501_1 (CYTOCHROME P450 2B4) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 4 / 7 | LEU A 160PHE A 161GLY A 164ILE A 322 | NoneGMP A 400 ( 4.8A)NoneNone | 0.82A | 2bdmA-2fqxA:undetectable | 2bdmA-2fqxA:19.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FQY_A_ADNA400_1 (MEMBRANE LIPOPROTEINTMPC) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 12 / 12 | ASP A 27PHE A 36ASN A 37GLY A 85ASP A 108MET A 158PHE A 161PHE A 186GLY A 212VAL A 237ASP A 238LYS A 260 | GMP A 400 (-2.9A)GMP A 400 (-3.8A)GMP A 400 (-3.3A)GMP A 400 ( 3.7A)GMP A 400 (-3.3A)GMP A 400 (-3.5A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A)GMP A 400 (-4.7A)GMP A 400 (-2.9A)GMP A 400 (-2.8A) | 0.73A | 2fqyA-2fqxA:54.3 | 2fqyA-2fqxA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QE6_A_SAMA400_0 (UNCHARACTERIZEDPROTEIN TFU_2867) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | ALA A 292GLY A 123GLY A 287ASP A 108GLY A 127 | NoneNoneNoneGMP A 400 (-3.3A)None | 0.88A | 2qe6A-2fqxA:undetectable | 2qe6A-2fqxA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_A_30BA500_1 (GENOME POLYPROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | ASP A 238GLY A 123ALA A 262ALA A 265ASP A 263 | GMP A 400 (-2.9A)NoneNoneNoneNone | 1.12A | 3keeA-2fqxA:undetectable | 3keeA-2fqxA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O1C_A_ADNA127_1 (HISTIDINE TRIADNUCLEOTIDE-BINDINGPROTEIN 1) |
4xba | APRATAXIN-LIKEPROTEIN (Schizosaccharomycespombe) | 5 / 10 | ASP A 63LEU A 73SER A 142HIS A 147HIS A 149 | GMP A 301 (-2.7A)NoneGMP A 301 ( 4.0A)GMP A 301 (-3.9A)GMP A 301 (-4.8A) | 0.42A | 3o1cA-4xbaA:8.0 | 3o1cA-4xbaA:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O1X_A_ADNA1450_1 (HISTIDINE TRIADNUCLEOTIDE-BINDINGPROTEIN 1) |
4xba | APRATAXIN-LIKEPROTEIN (Schizosaccharomycespombe) | 5 / 10 | ASP A 63LEU A 73SER A 142HIS A 147HIS A 149 | GMP A 301 (-2.7A)NoneGMP A 301 ( 4.0A)GMP A 301 (-3.9A)GMP A 301 (-4.8A) | 0.40A | 3o1xA-4xbaA:8.0 | 3o1xA-4xbaA:18.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QGZ_A_ADNA127_1 (HISTIDINE TRIADNUCLEOTIDE-BINDINGPROTEIN 1) |
4xba | APRATAXIN-LIKEPROTEIN (Schizosaccharomycespombe) | 5 / 10 | ASP A 63LEU A 73SER A 142HIS A 147HIS A 149 | GMP A 301 (-2.7A)NoneGMP A 301 ( 4.0A)GMP A 301 (-3.9A)GMP A 301 (-4.8A) | 0.40A | 3qgzA-4xbaA:8.1 | 3qgzA-4xbaA:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C9W_A_VGHA1158_1 (7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | LEU A 105MET A 24VAL A 82PHE A 36GLN A 39 | NoneNoneNoneGMP A 400 (-3.8A)None | 1.26A | 4c9wA-2fqxA:0.2 | 4c9wA-2fqxA:18.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_A_ADNA501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 7 / 12 | ASP A 27SER A 35ASN A 37ASP A 108PHE A 161PHE A 186GLY A 212 | GMP A 400 (-2.9A)GMP A 400 ( 4.6A)GMP A 400 (-3.3A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A) | 0.98A | 4pevA-2fqxA:39.8 | 4pevA-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_A_ADNA501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | ASP A 263VAL A 264ASP A 238PHE A 161ASP A 108 | NoneNoneGMP A 400 (-2.9A)GMP A 400 ( 4.8A)GMP A 400 (-3.3A) | 1.16A | 4pevA-2fqxA:39.8 | 4pevA-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_A_ADNA501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 9 / 12 | SER A 35PHE A 36ASN A 37ASP A 108PHE A 161PHE A 186GLY A 212ASP A 238LYS A 260 | GMP A 400 ( 4.6A)GMP A 400 (-3.8A)GMP A 400 (-3.3A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A)GMP A 400 (-2.9A)GMP A 400 (-2.8A) | 0.70A | 4pevA-2fqxA:39.8 | 4pevA-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_B_ADNB501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 7 / 12 | ASP A 27SER A 35ASN A 37ASP A 108PHE A 161PHE A 186GLY A 212 | GMP A 400 (-2.9A)GMP A 400 ( 4.6A)GMP A 400 (-3.3A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A) | 0.93A | 4pevB-2fqxA:39.7 | 4pevB-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_B_ADNB501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | ASP A 263VAL A 264ASP A 238PHE A 161ASP A 108 | NoneNoneGMP A 400 (-2.9A)GMP A 400 ( 4.8A)GMP A 400 (-3.3A) | 1.22A | 4pevB-2fqxA:39.7 | 4pevB-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_B_ADNB501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 10 / 12 | SER A 35PHE A 36ASN A 37GLY A 85ASP A 108PHE A 161PHE A 186GLY A 212ASP A 238LYS A 260 | GMP A 400 ( 4.6A)GMP A 400 (-3.8A)GMP A 400 (-3.3A)GMP A 400 ( 3.7A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A)GMP A 400 (-2.9A)GMP A 400 (-2.8A) | 0.84A | 4pevB-2fqxA:39.7 | 4pevB-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_C_ADNC501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 7 / 12 | ASP A 27SER A 35ASN A 37ASP A 108PHE A 161PHE A 186GLY A 212 | GMP A 400 (-2.9A)GMP A 400 ( 4.6A)GMP A 400 (-3.3A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A) | 0.88A | 4pevC-2fqxA:39.5 | 4pevC-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_C_ADNC501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | ASP A 263VAL A 264ASP A 238PHE A 161ASP A 108 | NoneNoneGMP A 400 (-2.9A)GMP A 400 ( 4.8A)GMP A 400 (-3.3A) | 1.07A | 4pevC-2fqxA:39.5 | 4pevC-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PEV_C_ADNC501_1 (MEMBRANE LIPOPROTEINFAMILY PROTEIN) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 9 / 12 | SER A 35PHE A 36ASN A 37ASP A 108PHE A 161PHE A 186GLY A 212ASP A 238LYS A 260 | GMP A 400 ( 4.6A)GMP A 400 (-3.8A)GMP A 400 (-3.3A)GMP A 400 (-3.3A)GMP A 400 ( 4.8A)GMP A 400 (-3.4A)GMP A 400 (-3.3A)GMP A 400 (-2.9A)GMP A 400 (-2.8A) | 0.59A | 4pevC-2fqxA:39.5 | 4pevC-2fqxA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 5 / 12 | MET A 158LEU A 160GLY A 164MET A 258PHE A 149 | GMP A 400 (-3.5A)NoneNoneNoneNone | 1.46A | 4udcA-2fqxA:undetectable | 4udcA-2fqxA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KLA_A_ACTA1505_0 (MATERNAL PROTEINPUMILIO) |
4xba | APRATAXIN-LIKEPROTEIN (Schizosaccharomycespombe) | 3 / 3 | HIS A 155LYS A 67PHE A 169 | NoneGMP A 301 (-2.9A)None | 1.18A | 5klaA-4xbaA:undetectable | 5klaA-4xbaA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QGL_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.68A | 5qglA-2fqxA:undetectable | 5qglA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QGU_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.69A | 5qguA-2fqxA:undetectable | 5qguA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QGV_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.70A | 5qgvA-2fqxA:undetectable | 5qgvA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QGW_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.70A | 5qgwA-2fqxA:undetectable | 5qgwA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QGX_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.70A | 5qgxA-2fqxA:undetectable | 5qgxA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QH1_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.70A | 5qh1A-2fqxA:undetectable | 5qh1A-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QHC_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.70A | 5qhcA-2fqxA:undetectable | 5qhcA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QHE_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.68A | 5qheA-2fqxA:undetectable | 5qheA-2fqxA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5QHF_A_ACTA301_0 (PEROXISOMAL COENZYMEA DIPHOSPHATASENUDT7) |
2fqx | MEMBRANE LIPOPROTEINTMPC (Treponemapallidum) | 3 / 3 | VAL A 151VAL A 210GLN A 124 | NoneGMP A 400 (-4.0A)GMP A 400 ( 4.7A) | 0.72A | 5qhfA-2fqxA:undetectable | 5qhfA-2fqxA:20.83 |